Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2014

Jun 2, 2014

31971_dirs_2014-06-02_0b1c81f9-2f16-44df-9fde-b85b20912f0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-06-01

Reporting Person: ABRAHAM WILLIAM (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-01 Common Stock M 400 Acquired 8034 Direct
2014-06-01 Common Stock F 145 $44.90 Disposed 7889 Direct
2014-06-01 Common Stock M 400 Acquired 8289 Direct
2014-06-01 Common Stock F 145 $44.90 Disposed 8144 Direct
2014-06-01 Common Stock M 400 Acquired 8544 Direct
2014-06-01 Common Stock F 145 $44.90 Disposed 8399 Direct
2014-06-01 Common Stock M 400 Acquired 8799 Direct
2014-06-01 Common Stock F 145 $44.90 Disposed 8654 Direct
2014-06-01 Common Stock M 400 Acquired 9054 Direct
2014-06-01 Common Stock F 145 $44.90 Disposed 8909 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-06-01 Rsus (restricted Stock Units) $0 M 400 Disposed 2019-06-01 Common Stock (400) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 400 Disposed 2020-06-01 Common Stock (400) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 400 Disposed 2021-06-01 Common Stock (400) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 400 Disposed 2022-06-01 Common Stock (400) Direct
2014-06-01 Rsus (restricted Stock Units) $0 M 400 Disposed 2023-06-01 Common Stock (400) Direct
2014-06-01 Rsus (restricted Stock Units) $0 A 1300 Acquired 2024-06-01 Common Stock (1300) Direct
2014-06-01 Sars (Stock Appreciation Rights) $44.90 A 3250 Acquired 2024-06-01 Common Stock (3250) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.